Shotaro Tatekawa Selected Research

Radiation Dose Fractionation

1/2022

Poly (ADP-ribose) polymerase inhibitors sensitize cancer cells to hypofractionated radiotherapy through altered selection of DNA double-strand break repair pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shotaro Tatekawa Research Topics

Disease

9	Neoplasms (Cancer) 04/2022 - 11/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015 - 11/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 01/2022
2	Genetic Translocation (Chromosomal Translocation) 01/2022 - 01/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 09/2019
1	Adenocarcinoma 01/2022
1	Tetraploidy 01/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2021
1	Carcinoma (Carcinomatosis) 05/2021
1	Alzheimer Disease (Alzheimer's Disease) 09/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2017
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2017
1	Bacterial Pneumonia 01/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2016
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 12/2015
1	Multi-centric Castleman's Disease 06/2015
1	Ascites 06/2015
1	Multiple Myeloma 04/2015
1	Bronchiolitis Obliterans Syndrome 01/2014
1	Autoimmune Pancreatitis 01/2014
1	Pancreatitis 01/2014
1	Carcinogenesis 11/2013
1	Pituitary Neoplasms (Pituitary Adenoma) 11/2013
1	Acromegaly 11/2013

Drug/Important Bio-Agent (IBA)

3	Radiation-Sensitizing AgentsIBA 01/2022 - 09/2019
2	Prednisolone (Predate)FDA LinkGeneric 01/2016 - 06/2015
2	Bortezomib (Velcade)FDA Link 01/2016 - 04/2015
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	Polo-Like Kinase 1IBA 01/2022
1	veliparibIBA 01/2022
1	olaparibIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	6-methyladenineIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	3' Untranslated Regions (3' UTR)IBA 01/2022
1	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 01/2022
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	N-methyladenosineIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	MethyltransferasesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 10/2021
1	S-Adenosylmethionine (Ademetionine)IBA 10/2021
1	Niacinamide (Nicotinamide)FDA LinkGeneric 10/2021
1	CarbonIBA 10/2021
1	CotinineIBA 05/2021
1	Carbon MonoxideIBA 05/2021
1	dihydroouabainIBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 09/2019
1	(2'- (4- aminophenyl)- (2,5'- bi- 1H- benzimidazol)- 5- amine)IBA 09/2019
1	Rituximab (Mabthera)FDA Link 05/2017
1	AutoantibodiesIBA 01/2016
1	AntigensIBA 01/2016
1	Lenalidomide (CC 5013)FDA Link 01/2016
1	RHO(D) antibody (anti-D)IBA 01/2016
1	Netrin-1IBA 12/2015
1	tocilizumab (atlizumab)FDA Link 06/2015
1	Thalidomide (Thalomid)FDA Link 06/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Gabexate (Foy)IBA 01/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2013
1	Growth Hormone (Somatotropin)IBA 11/2013

Therapy/Procedure

6	Radiotherapy 01/2022 - 01/2020
4	Therapeutics 04/2022 - 04/2015
2	Drug Therapy (Chemotherapy) 04/2022 - 11/2013
2	Transplantation 01/2016 - 01/2015
1	Immunotherapy 04/2022
1	Radiation Dose Fractionation 01/2022
1	Cell Transplantation 01/2016
1	Hematopoietic Stem Cell Transplantation 01/2015
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2014